×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IKNA – ikena oncology, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IKNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/30
01:19 pm
ikna
Ikena Oncology (IKNA) Moves to Buy: Rationale Behind the Upgrade [Yahoo! Finance]
Neutral
Report
Ikena Oncology (IKNA) Moves to Buy: Rationale Behind the Upgrade [Yahoo! Finance]
12/23
08:11 pm
ikna
Ikena Oncology, Inc. (NASDAQ: IKNA) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $2.00 price target on the stock.
High
Report
Ikena Oncology, Inc. (NASDAQ: IKNA) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $2.00 price target on the stock.
12/23
08:42 am
ikna
Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement [Yahoo! Finance]
Medium
Report
Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement [Yahoo! Finance]
12/23
08:30 am
ikna
Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement
Medium
Report
Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement
11/11
08:09 am
ikna
Ikena Oncology, Inc. (NASDAQ: IKNA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Low
Report
Ikena Oncology, Inc. (NASDAQ: IKNA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
11/9
10:11 am
ikna
Ikena Oncology Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.40 loss in 3Q 2023) [Yahoo! Finance]
Low
Report
Ikena Oncology Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.40 loss in 3Q 2023) [Yahoo! Finance]
11/7
08:30 am
ikna
Ikena Oncology Reports Third Quarter 2024 Financial Results
Low
Report
Ikena Oncology Reports Third Quarter 2024 Financial Results
Date
Time
Symbol
Headline
Impact
12/31
03:45 pm
ikna
Form SCHEDULE 13G Ikena Oncology, Inc. Filed by: BML Investment Partners, L.P.
Low
Report
Form SCHEDULE 13G Ikena Oncology, Inc. Filed by: BML Investment Partners, L.P.
12/23
08:41 am
ikna
Form 425 Ikena Oncology, Inc. Filed by: Ikena Oncology, Inc.
Medium
Report
Form 425 Ikena Oncology, Inc. Filed by: Ikena Oncology, Inc.
12/23
08:38 am
ikna
Form 8-K Ikena Oncology, Inc. For: Dec 23
Medium
Report
Form 8-K Ikena Oncology, Inc. For: Dec 23
11/14
05:05 pm
ikna
Form SC 13G Ikena Oncology, Inc. Filed by: Blue Owl Capital Holdings LP
Low
Report
Form SC 13G Ikena Oncology, Inc. Filed by: Blue Owl Capital Holdings LP
11/13
04:06 pm
ikna
Form SC 13G/A Ikena Oncology, Inc. Filed by: BRISTOL MYERS SQUIBB CO
Low
Report
Form SC 13G/A Ikena Oncology, Inc. Filed by: BRISTOL MYERS SQUIBB CO
11/7
08:01 am
ikna
Form 10-Q Ikena Oncology, Inc. For: Sep 30
Low
Report
Form 10-Q Ikena Oncology, Inc. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: